engleski

Implementation of Pharmacoeconomics to Support Pharmaceutical R&D Decisions: Workshop

Learning Objectives: 1. To facilitate the utilization of health economic input into pharmaceutical R&D decisions ; 2. To develop technical skills in the application of economic models to translate the “target product profile” to strategic pricing assumptions and consequently to conduct “go & no go” decisions Course Description: Assessment of the economic value is increasingly important in the pricing and reimbursement process of new pharmaceuticals due to the scarcity of public resources. As a consequence, pharmaceutical research and development face the need for a new type of development strategy. In the R&D process, health economic aspects should be taken into account, especially in 1) the priorisation of research areas, 2) the pricing assumptions of drug candidates, and 3) the go & no go decisions of drug candidates, including the selection of target indications. The workshop provides a theoretical overview of health economic activities in the R&D process and provides pragmatic case studies on how to make decisions in the real world. General presentations will introduce the topic. Then a series of password protected economic models will add more and more complexity to a pragmatic case study on a drug candidate in 3 potential indications. Participants should calculate the “economically justifiable price” and apply this information for making “go & no go” decisions. Participants should bring their own computers with Excel software to complete the case study. Level: Intermediate. This course is designed for clinical pharmacologists, R&D experts, and decision-makers (including public policymakers and regulators, academia, and industry) who are wishing to understand the applicability and technical aspects of health economic methodologies to support the evidence base of R&D decisions. Course structure: Health policy environment for new pharmaceuticals: Lecture Strategic imperatives of pharmaceutical R&D: Lecture Health economic support in the R&D process: Lecture Principles of strategic pricing: Lecture Strategic pricing (case study): Computer exercise Principles of “go & no go” decisions: Lecture & Discussion “Go & no go” decisions (case study): Computer exercise Prereading: Bodrogi J, Kaló Z. Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development. Br J Pharmacol. 2010. 159. 7. 1367-73.

Pharmacoeconomics ; Pharmaceutical R&D Decisions ; Workshop

nije evidentirano